Evidence map›Paper›PMID 42215600›Full record

ArticleCommunications chemistry2026

CholBindNet as an interpretable neural network for cholesterol-binding site classification.

Alexis Hernandez, Aashish Bhatt, Ivan Revilla, Jacob Ede Levine, Sai Chandra Kosaraju, Yun Lyna Luo

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Alexis HernandezComputer Science Department, California State Polytechnic University, Pomona, CA, USA.
Aashish BhattDepartment of Biotechnology and Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Ivan RevillaDepartment of Biotechnology and Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA.
Jacob Ede LevineComputer Science Department, California State Polytechnic University, Pomona, CA, USA.
Sai Chandra KosarajuComputer Science Department, California State Polytechnic University, Pomona, CA, USA. skosaraju@cpp.edu.ORCID http://orcid.org/0000-0002-4332-6217
Yun Lyna LuoDepartment of Biotechnology and Pharmaceutical Sciences, Western University of Health Sciences, Pomona, CA, USA. luoy@westernu.edu.ORCID http://orcid.org/0000-0003-3581-754X

Funding

PHARMACOLOGICAL MODULATION OF PIEZO1 CHANNELSR01GM130834 · NIGMS · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI Yun Lyna LUO, Jerome Lacroix · 2019 to 2026
$2.8M
Breakthrough Molecular Dynamics Research via an Anton 3 SupercomputerR24GM154042 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI Philip D. Blood · 2024 to 2026
$2.3M
NIGMS NIH HHS R01 GM130834NIGMS NIH HHS R24 GM154042U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM130834
6 · The paper itself

Abstract

Cholesterol is a key modulator of membrane protein structure and function, yet predicting cholesterol-binding sites remains challenging due to its non-druglike physicochemical properties. Here, we curated more than 800 high-resolution transmembrane protein structures containing cholesterol, and developed an interpretable, atom-based graph neural network, called CholBindNet. A positive-unlabeled (PU) training strategy was employed to address the scarcity of negative samples due to the promiscuous nature of cholesterol binding. We show that CholBindNet substantially outperforms existing machine learning models trained on general ligand-binding datasets, including AlphaFold3, P2Rank, and DiffDock. The performance and generalizability of the model on unseen membrane proteins were further demonstrated by rapidly assessing cholesterol-binding sites in the PIEZO2 ion channel against all-atom molecular dynamics (MD) simulations conducted on Anton3 supercomputer. Additionally, strong model interpretability was achieved for CholBindNet through atom-level feature encoding, Grad-CAM visualization, and attention-based scoring analysis. Overall, CholBindNet provides an efficient and scalable approach for classifying and ranking cholesterol-binding sites on membrane proteins, achieving performance comparable to computationally expensive MD simulations while offering rich biophysical insights into the atomic-level spatial patterns beyond amino-acid sequence. This work lays the foundation for future deep-learning models targeting membrane protein drug-binding sites and cholesterol-modulated therapeutics.

Identifiers

PMID42215600
PMCPMC13574765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.